Sabin S Egger
Overview
Explore the profile of Sabin S Egger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schlatter C, Egger S, Tchambaz L, Krahenbuhl S
Drug Saf
. 2009 Jun;
32(7):561-78.
PMID: 19530743
Dose adjustment of psychotropic drugs in patients with liver cirrhosis may be important as most of these drugs are predominantly eliminated by the liver and many of them are associated...
2.
Egger S, Ratz Bravo A, Hess L, Schlienger R, Krahenbuhl S
Drugs Aging
. 2007 May;
24(5):429-40.
PMID: 17503898
Background And Objective: Elderly patients may be at higher risk of drug-drug interactions (DDIs) because of polypharmacy. This study evaluated age-specific differences in the prevalence of clinically relevant potential DDIs...
3.
Egger S, Bachmann A, Hubmann N, Schlienger R, Krahenbuhl S
Drugs Aging
. 2006 Oct;
23(10):823-37.
PMID: 17067185
Background And Objective: Inappropriate drug use is one of the risk factors for adverse drug reactions in the elderly. We hypothesised that, in elderly patients, geriatricians are more aware of...
4.
Bodmer M, Egger S, Hohenstein E, Beltraminelli H, Krahenbuhl S
Ann Pharmacother
. 2006 Aug;
40(9):1688-90.
PMID: 16896017
Objective: To report a case of lichenoid drug eruption (LDE) after starting antihypertensive treatment with nebivolol, a cardioselective beta-blocker. Case Summary: Five weeks after starting treatment with nebivolol, a 62-year-old...
5.
Egger S, Krahenbuhl S, Schlienger R
Schweiz Monatsschr Zahnmed
. 2006 Jan;
115(12):1209-18.
PMID: 16408825
Dentists may be confronted with adverse drug reactions (ADRs) in their dental practice, and are--like other health professionals--obliged to report certain ADRs. The aim of this article is to sensitise...
6.
Egger S, Sawatzki M, Drewe J, Krahenbuhl S
Pharmacotherapy
. 2005 Jun;
25(6):881-5.
PMID: 15927907
Dalteparin and other low-molecular-weight heparins are frequently used for the treatment of deep vein thrombosis and for other indications. Unlike unfractionated heparin (UFH), dalteparin is mainly cleared through the kidney;...
7.
Ratz Bravo A, Egger S, Crespo S, Probst W, Krahenbuhl S
Ann Pharmacother
. 2004 Jun;
38(7-8):1189-93.
PMID: 15187206
Objective: To report the occurrence of lithium intoxication in a patient with bipolar disorder after adding rofecoxib to the medication regimen. Case Summary: A 68-year-old woman with bipolar disorder under...
8.
Egger S, Drewe J, Schlienger R
Eur J Clin Pharmacol
. 2003 Mar;
58(11):773-8.
PMID: 12634985
Objective: Information on the frequency of drug combinations with the potential to induce dangerous drug-drug interactions (DDIs) in patients discharged from the hospital is scarce. With the present study, we...